Articles

For those who read my recent article which discussed the value of the aerospace sector to the UK economy, you will know that there are certainly green shoots of recovery in the sector after the trials of the pandemic.

One of the defining features of modern life is consumer electronics. Smart devices with computational power that would have been staggering a few decades ago are now so commonplace that they’re completely taken for granted, and many people are never without their smartphone.

Tune in and listen to Aimava's Andrew Gaule discussing with Simon Portman, of Counsel, Marks and Clerk, IP and the legal challenges required to ensure the most is made of IP.

There has been a spattering of case law over the last few years concerned with clinical trial proposals as prior art for patent applications. The status of clinical trial proposals as prior art is particularly relevant to patent applications relating to medical products and medical uses, and this issue has recently been of relevance to one of our clients’ patents.

UK economic growth over the last few years has been lacklustre. With growth of only 1.7% compared to pre-pandemic levels, the UK’s growth has been the second-lowest in the G7 and behind the US and France, with only Germany having lower growth over this period. In addition, the UK’s productivity, i.e. economic output per hour worked, has remained stubbornly flat over the last few years, while the US, France and Germany have stretched their lead in productivity levels.

In the latest Dead Cat Live Cat interview with Quantum specialists, host Rhian Granleese, Partner at Marks & Clerk, interviews guest Lene B. Oddershede, Senior Vice President at the Novo Nordisk Foundation.

The Federal Court recently upheld the decision of the Trademarks Opposition Board (the “Board”) refusing an application filed by PDM Parthian Distributer & Marketing Adviser GmbH (“PDM”) to register the trademark BLACK PUNK on the basis that it is confusing with the trademark PUNK, owned by Brewdog PLC (“Brewdog”).

The Beijing IP Court recently upheld a CNIPA decision to cancel a class 35 trade mark registration despite proof of use submitted by the registrant. This case highlights the difficulty in defending a class 35 trade mark registration, often obtained for defensive purposes, against a non-use challenge in China.

Medical technology (medtech ) is a dynamic and rapidly growing sector in Singapore. Today, Singapore is home to all of the Top 30 multinational medtech companies, which carry out a range of activities including research and development, and manufacturing.